Stock Research for OMCL


Featured Broker: Ally Invest

Get the due diligence for another stock.


OMCL Stock Chart & Research Data

The OMCL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OMCL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


OMCL Due diligence Resources & Stock Charts

The OMCL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OMCL Detailed Price Forecast - CNN Money CNN View OMCL Detailed Summary - Google Finance
Yahoo View OMCL Detailed Summary - Yahoo! Finance Zacks View OMCL Stock Research & Analysis -

Stock Analysis

TradeIdeas View OMCL Trends & Analysis - Trade-Ideas Barrons View OMCL Major Holders - Barrons
NASDAQ View OMCL Call Transcripts - NASDAQ Seeking View OMCL Breaking News & Analysis - Seeking Alpha
Spotlight View OMCL Annual Report - OTC Report View OMCL OTC Short Report -
TradeKing View OMCL Fundamentals - TradeKing Charts View OMCL SEC Filings - Bar Chart
WSJ View Historical Prices for OMCL - The WSJ Morningstar View Performance/Total Return for OMCL - Morningstar
MarketWatch View the Analyst Estimates for OMCL - MarketWatch CNBC View the Earnings History for OMCL - CNBC
StockMarketWatch View the OMCL Earnings - StockMarketWatch MacroAxis View OMCL Buy or Sell Recommendations - MacroAxis
Bullish View the OMCL Bullish Patterns - American Bulls Short Pains View OMCL Short Pain Metrics -

Social Media Mentions

StockTwits View OMCL Stock Mentions - StockTwits PennyStocks View OMCL Stock Mentions - PennyStockTweets
Twitter View OMCL Stock Mentions - Twitter Invest Hub View OMCL Investment Forum News - Investor Hub
Yahoo View OMCL Stock Mentions - Yahoo! Message Board Seeking Alpha View OMCL Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for OMCL - Insider Cow View Insider Transactions for OMCL - Insider Cow
CNBC View OMCL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OMCL - OTC Markets
Yahoo View Insider Transactions for OMCL - Yahoo! Finance NASDAQ View Institutional Holdings for OMCL - NASDAQ

Stock Charts

FinViz View OMCL Stock Insight & Charts - StockCharts View OMCL Investment Charts -
BarChart View OMCL Stock Overview & Charts - BarChart Trading View View OMCL User Generated Charts - Trading View

Latest Financial News for OMCL

Middlesex Hospital Bolsters Pharmacy Safety and Compliance by Extending Wolters Kluwer's Simplifi 797 with Omnicell's IVX Workflow
Posted on Tuesday September 18, 2018

MOUNTAIN VIEW, Calif., Sept. 18, 2018 /PRNewswire/ -- Wolters Kluwer, Health and Omnicell, Inc. (OMCL) today announced that Connecticut-based Middlesex Hospital has extended its use of Simplifi 797® and has chosen Omnicell's IVX Workflow to automate the hospital's sterile compounding operations. The companies provide a turnkey solution that combines the expertise and best-practice approach of quality management solution Simplifi 797 with the advanced IVX Workflow technology from Omnicell. Scrutiny of compounding policies followed a high-profile meningitis outbreak in 2012 that brought to light weaknesses in the state-level oversight of these potentially risky drugs and the contamination-prone environments where they are formulated.

Omnicell Continues to Pursue Buyouts, Costs on the Rise
Posted on Monday September 17, 2018

Omnicell (OMCL) progresses well with its strategy to grow inorganically. Rising operating expenses a concern.

Rob Seim to retire and join Omnicell Board of Directors
Posted on Friday September 14, 2018

MOUNTAIN VIEW, Calif., Sept. 14, 2018 /PRNewswire/ -- Omnicell, Inc. (OMCL), the leading provider of medication and supply management technology across the continuum of care, today announced that Rob Seim, President of Global Automation and Medication Adherence, has indicated his intent to retire as of March 15, 2019. The company also announced the appointment of Mr. Seim to the Board of Directors following his retirement. Mr. Seim served Omnicell as its Chief Financial Officer for nearly 10 years and was also Executive Vice President of Finance, Administration, and Manufacturing during that time. For the past three years, Mr. Seim has served as President of Global Automation and Medication Adherence which includes responsibility for all of the non-US business of Omnicell, several product lines, and worldwide manufacturing. During his 13 years at Omnicell, revenue grew over 550% and market valuation grew over 8 fold.

Has Omnicell Inc (NASDAQ:OMCL) Got Enough Cash?
Posted on Thursday September 06, 2018

Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Omnicell Inc (NASDAQ:OMCL) with a market-capitalization of US$2.74b, rarely draw their attention. However, generally ignored mid-caps haveRead More...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.